Start » Shop » Robican (Methocarbamol) 500 mg – 10 tablets

Robican (Methocarbamol) 500 mg - 10 tablets

Robican (Methocarbamol) 500 mg – 10 tablets

5,70 $

Robican 500 mg is an oral central muscle relaxant containing methocarbamol 500 mg for short-term relief of muscle spasm associated with musculoskeletal conditions, commonly used in acute strains and sprains.

SKU: ROBI500 Category:

Description

Robican (Methocarbamol) 500 mg

Robican 500 mg is a brand name for methocarbamol, an oral prescription medicine used for the relief of discomfort associated with acute, painful musculoskeletal conditions. It is classified as a central nervous system depressant with musculoskeletal relaxant properties.

Active Ingredient and Medicine Class

The verified active ingredient is methocarbamol. Regulatory labeling describes it as a carbamate derivative of guaifenesin and a skeletal muscle relaxant used for short-term symptomatic treatment of musculoskeletal pain and spasm. It does not act directly on skeletal muscle fibers, the motor end plate, or the nerve fiber.

Established Medical Uses

Official prescribing information states that methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. Published reviews describe its use in acute musculoskeletal pain, including low back pain, although evidence for benefit is more limited than for some other muscle relaxants.

How It Works

The exact mechanism is not fully established. Labeling indicates that methocarbamol acts mainly through central nervous system depressant effects and may relieve symptoms by reducing the sensation of muscle spasm and discomfort rather than by directly relaxing muscle tissue.

Important Safety Information

Methocarbamol should not be used in people with known hypersensitivity to methocarbamol or any tablet component. Important precautions include additive sedation with alcohol and other central nervous system depressants. Regulatory labeling also warns that safety in pregnancy has not been established and reports of fetal or congenital abnormalities have been described; use in pregnancy requires careful medical judgment.

Clinically significant interactions mainly involve other sedating medicines, including other CNS depressants, because combined effects may increase drowsiness and impairment.

Possible Side Effects

Reported adverse effects include drowsiness, dizziness, lightheadedness, and other symptoms related to CNS depression. More serious reactions can include severe sedation, confusion, and problems associated with overdose, especially when taken with alcohol or other sedating drugs.

Scientific Evidence

Peer-reviewed reviews of skeletal muscle relaxants note that methocarbamol is used for acute musculoskeletal pain, but the evidence for efficacy is limited or inconsistent compared with some other agents. In practice, it is considered a short-term symptomatic option rather than a disease-modifying treatment.

Medical Information Notice

This summary is for educational purposes only and is based on sources available at the time of review. It does not replace the official patient leaflet, prescribing information, or individual assessment by a qualified healthcare professional.

Medical Sources